Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Broadcom
AVGO
|
+$2.09B |
| 2 |
Mastercard
MA
|
+$2.06B |
| 3 |
UnitedHealth
UNH
|
+$1.3B |
| 4 |
Coca-Cola
KO
|
+$1.17B |
| 5 |
Marsh & McLennan
MMC
|
+$1.1B |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.55B |
| 2 |
Apple
AAPL
|
+$1.51B |
| 3 |
JPMorgan Chase
JPM
|
+$1.34B |
| 4 |
General Dynamics
GD
|
+$1.25B |
| 5 |
Wells Fargo
WFC
|
+$1.17B |
Sector Composition
| 1 | Technology | 21.49% |
| 2 | Healthcare | 18.42% |
| 3 | Financials | 15.97% |
| 4 | Consumer Discretionary | 9.49% |
| 5 | Industrials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Nuvation Bio
NUVB
$1.16B
| $1.22M | ﹤0.01% |
692,673
+16,649
| +2% | +$29.3K |
|
1577
Affiliated Managers Group
AMG
$6.65B
| $1.22M | ﹤0.01% |
7,243
-416
| -5% | -$69.9K |
|
1578
Arcellx
ACLX
$3.99B
| $1.21M | ﹤0.01% |
18,439
-1,254
| -6% | -$82.3K |
|
1579
Evergy
EVRG
$16.5B
| $1.2M | ﹤0.01% |
+17,452
| New | +$1.2M |
|
1580
Bandwidth Inc
BAND
$468M
| $1.19M | ﹤0.01% |
+91,035
| New | +$1.19M |
|
1581
NewtekOne
NEWT
$305M
| $1.18M | ﹤0.01% |
98,676
-154,951
| -61% | -$1.85M |
|
1582
Catalyst Pharmaceutical
CPRX
$2.47B
| $1.17M | ﹤0.01% |
48,447
-3,103
| -6% | -$75.2K |
|
1583
Erasca
ERAS
$457M
| $1.16M | ﹤0.01% |
850,147
+384,475
| +83% | +$527K |
|
1584
Expedia Group
EXPE
$26.9B
| $1.16M | ﹤0.01% |
6,914
-7,141
| -51% | -$1.2M |
|
1585
Rivian
RIVN
$16.7B
| $1.16M | ﹤0.01% |
92,798
+18,230
| +24% | +$227K |
|
1586
Vanguard Small-Cap Value ETF
VBR
$31.6B
| $1.15M | ﹤0.01% |
6,197
| – | – |
|
1587
Aflac
AFL
$56.8B
| $1.15M | ﹤0.01% |
10,311
-621
| -6% | -$69K |
|
1588
Teradyne
TER
$18.4B
| $1.14M | ﹤0.01% |
13,819
-735
| -5% | -$60.7K |
|
1589
Tourmaline Bio
TRML
$1.22B
| $1.14M | ﹤0.01% |
74,739
+6,140
| +9% | +$93.4K |
|
1590
ArriVent BioPharma
AVBP
$767M
| $1.13M | ﹤0.01% |
61,348
+19,427
| +46% | +$359K |
|
1591
Vanguard FTSE Emerging Markets ETF
VWO
$99.1B
| $1.13M | ﹤0.01% |
+24,986
| New | +$1.13M |
|
1592
Altimmune
ALT
$328M
| $1.12M | ﹤0.01% |
224,954
+19,721
| +10% | +$98.6K |
|
1593
Southern First Bancshares
SFST
$366M
| $1.12M | ﹤0.01% |
34,109
-31,331
| -48% | -$1.03M |
|
1594
Expro
XPRO
$1.41B
| $1.12M | ﹤0.01% |
112,602
+22,166
| +25% | +$220K |
|
1595
Omeros
OMER
$290M
| $1.12M | ﹤0.01% |
+136,002
| New | +$1.12M |
|
|
VERV
1596
DELISTED
Verve Therapeutics
VERV
| $1.12M | ﹤0.01% |
244,183
-117,315
| -32% | -$536K |
|
1597
Cummins
CMI
$55.3B
| $1.11M | ﹤0.01% |
3,529
-110
| -3% | -$34.5K |
|
1598
Rigel Pharmaceuticals
RIGL
$646M
| $1.1M | ﹤0.01% |
61,398
+26,415
| +76% | +$475K |
|
1599
Esperion Therapeutics
ESPR
$502M
| $1.1M | ﹤0.01% |
761,980
+201,704
| +36% | +$290K |
|
1600
BorgWarner
BWA
$9.3B
| $1.09M | ﹤0.01% |
38,216
-53,250
| -58% | -$1.53M |
|